Eaton Vance Management’s Kyntra Bio KYNB Stock Holding History

Eaton Vance Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.23M	Hold	3,779	–	–	﹤0.01%	1182
2022 Q2	$998K	Hold	3,779	–	–	﹤0.01%	1254
2022 Q1	$1.14M	Hold	3,779	–	–	﹤0.01%	1335
2021 Q4	$1.33M	Hold	3,779	–	–	﹤0.01%	1119
2021 Q3	$966K	Hold	3,779	–	–	﹤0.01%	1097
2021 Q2	$2.52M	Hold	3,779	–	–	﹤0.01%	958
2021 Q1	$3.28M	Hold	3,779	–	–	﹤0.01%	851
2020 Q4	$3.5M	Hold	3,779	–	–	0.01%	797
2020 Q3	$3.88M	Hold	3,779	–	–	0.01%	688
2020 Q2	$3.83M	Sell	3,779 -3	-0.1%	-$2.79K	0.01%	660
2020 Q1	$3.29M	Buy	3,782 +3	+0.1%	+$2.98K	0.01%	642
2019 Q4	$4.05M	Hold	3,779	–	–	0.01%	663
2019 Q3	$3.49M	Buy	3,779 +1,699	+82%	+$1.87M	0.01%	677
2019 Q2	$2.35M	Hold	2,080	–	–	0.01%	772
2019 Q1	$2.83M	Buy	2,080 +360	+21%	+$488K	0.01%	688
2018 Q4	$1.99M	Hold	1,720	–	–	0.01%	724
2018 Q3	$2.61M	Hold	1,720	–	–	0.01%	689
2018 Q2	$2.69M	Sell	1,720 -1,720	-50%	-$2.24M	0.01%	668
2018 Q1	$3.97M	Buy	3,440 +1,720	+100%	+$2.27M	﹤0.01%	711
2017 Q4	$2.04M	Hold	1,720	–	–	﹤0.01%	706
2017 Q3	$2.31M	Hold	1,720	–	–	0.01%	661
2017 Q2	$1.39M	Buy	1,720 +800	+87%	+$557K	﹤0.01%	747
2017 Q1	$567K	Buy	+920	New	+$560K	﹤0.01%	878

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Eaton Vance Management's KYNB Position: Q3 2022 in Review

Eaton Vance Management held its Kyntra Bio (KYNB) position steady in Q3 2022 at 3,779 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Eaton Vance Management first reported a position in KYNB in Q1 2017 and has held it in 23 quarters since. The position peaked at $4.05M in Q4 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

Eaton Vance Management held 3,779 shares of Kyntra Bio worth $1.23M as of Q3 2022.
Eaton Vance Management left its Kyntra Bio share count unchanged in Q3 2022.
Kyntra Bio made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1182 holding.
Eaton Vance Management first reported a position in Kyntra Bio in Q1 2017 and has held it in 23 quarters since.
Eaton Vance Management's Kyntra Bio position peaked at $4.05M in Q4 2019.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.